← Eichor
Study identifier: NCT07642232 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effects of Somatic Movement Therapy vs Core Strengthening in Premenstrual Syndrome

Condition: Premenstrual Syndrome  ·  Sponsor: Riphah International University

PhaseNA
Planned participants36
Who can joinFemale, 18 Years to 35 Years
Healthy volunteersYes

About this study

Premenstrual Syndrome (PMS) is a multifactorial disorder affecting women of reproductive age, causing physical discomfort, emotional instability, and reduced quality of life. This randomized clinical trial aims to compare the effects of Somatic Movement Therapy (SMT) and Core Strengthening Exercises (CSE) on symptom severity, perceived stress, and quality of life in 34 female participants aged 18-35 years diagnosed with PMS according to ACOG criteria. Group A will receive SMT, while Group B will perform CSE over a 6-week program. Outcomes will be measured using PSST, PSS-10, and WHOQOL-BREF, with data analyzed through SPSS version 27.

This description comes directly from the study's public registry record.

Talk to the study team

Imran Amjad, PHD*  ·  03324390125  ·  imran.amjad@riphah.edu.pk

Imran Amjad, PHD*  ·  0515481826  ·  imran.amjad@riphah.edu.pk

Always discuss trial participation with your own doctor first.

Locations (1)

Ghurki Trust HoapitalLahore, Punjab Province, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07642232